Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Esperion Therapeutics and Cleveland Clinic in HDL therapy deal
July 2010
SHARING OPTIONS:

PLYMOUTH, Mich.Esperion Therapeutics, a privately held biopharmaceutical company focused on cardiovascular and metabolic diseases, has established a collaborative research agreement with Cleveland Clinic, one of the world's leading academic medical centers. The collaboration will work to advance research targeting new high-density lipoprotein (HDL) therapies to treat cardiovascular disease and was developed in conjunction with Cleveland Clinic Innovations, the corporate venturing arm of Cleveland Clinic. The collaboration will further expand Esperion's established focus on research in lipid regulating therapies. Financial details were not released.  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.